Literature DB >> 6298945

Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.

J J Costanzi, L R Morgan, J Hokanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6298945

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  10 in total

1.  Failure of response to ifosfamide in squamous cell bronchogenic carcinoma.

Authors:  J Banks; E G Anderson; A P Smith
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity.

Authors:  D M Nanus; D P Kelsen; R Lipperman; M Eisenberger
Journal:  Invest New Drugs       Date:  1988-09       Impact factor: 3.850

3.  Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.

Authors:  P Drings; U Abel; H Bülzebruck; P Stiefel; M Kleckow; H G Manke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 4.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

5.  Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer.

Authors:  U Gatzemeier; M Heckmayr; D K Hossfeld; R Zschaber; W Achterrath; L Lenaz
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.

Authors:  S D Chetiyawardana; M H Cullen; R C Joshi; C M Woodroffe
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Phase I study of high-dose cisplatin, ifosfamide, and etoposide.

Authors:  E A Perez; P C Sowray; S L Gardner; D R Gandara
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 8.  Comparative activity of ifosfamide and cyclophosphamide.

Authors:  W Brade; S Seeber; K Herdrich
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix.

Authors:  R E Coleman; P G Harper; C Gallagher; R Osborne; E M Rankin; A C Silverstone; M L Slevin; R L Souhami; J S Tobias; C W Trask
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 10.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.